(Q70758585)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Early dosing practices and effectiveness of recombinant human erythropoietin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

N R Powe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

R I Griffiths

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

J W Greer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A J Watson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

G F Anderson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

G de Lissovoy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

R J Herbert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

P W Eggers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

R A Milam

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

P K Whelton

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

English

0 references

publication date

1 May 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

1125-1133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1993.158

13 October 2019

exact match

0 references

cites work

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1993.158

1 reference

7 January 2021

Hematopoietic growth factors. Biology and clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Biotechnology--the enormous cost of success

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Acquisition and application of new medical knowledge by anesthesiologists: three recent examples

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

The Dissemination of New Medical Information

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

How cardiologists learn about echocardiography. A reminder for medical educators and legislators

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

How internists learned about cimetidine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

The case for abandonment of explosive anesthetic agents

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Effectiveness in Health Care

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Impact of claims data research on clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Practical approach to initiation of recombinant human erythropoietin therapy and prevention and management of adverse effects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Recombinant human erythropoietin: physiology, pathophysiology of anemia in renal failure, and economic aspects related to dosing.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Iron status in patients receiving erythropoietin for dialysis-associated anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Recombinant human erythropoietin: implications for nephrology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Recombinant erythropoietin and Medicare payment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.158

7 January 2021

Identifiers

DOI

10.1038/KI.1993.158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8510392%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference